A detailed history of Harvard Management CO Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Harvard Management CO Inc holds 170,000 shares of TXG stock, worth $2.26 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
170,000
Previous 170,000 -0.0%
Holding current value
$2.26 Million
Previous $3.31 Million 16.09%
% of portfolio
0.22%
Previous 0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$40.86 - $62.98 $659,602 - $1.02 Million
-16,143 Reduced 8.67%
170,000 $7.01 Million
Q2 2021

Aug 13, 2021

BUY
$134.22 - $202.37 $13 Million - $19.6 Million
96,667 Added 108.04%
186,143 $36.5 Million
Q1 2021

May 07, 2021

BUY
$140.25 - $196.86 $12.5 Million - $17.6 Million
89,476 New
89,476 $16.2 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.27B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Harvard Management CO Inc Portfolio

Follow Harvard Management CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvard Management CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harvard Management CO Inc with notifications on news.